Invention Grant
- Patent Title: SH3 domain derivatives
-
Application No.: US15742934Application Date: 2016-07-08
-
Publication No.: US11060084B2Publication Date: 2021-07-13
- Inventor: Kalle Saksela
- Applicant: Next Biomed Therapies Oy
- Applicant Address: FI Helsinki
- Assignee: Next Biomed Therapies Oy
- Current Assignee: Next Biomed Therapies Oy
- Current Assignee Address: FI Helsinki
- Agency: Laine IP Oy
- Priority: FI20155554 20150710
- International Application: PCT/FI2016/050509 WO 20160708
- International Announcement: WO2017/009533 WO 20170119
- Main IPC: C12N15/10
- IPC: C12N15/10 ; C07K14/47 ; C12N15/63

Abstract:
The present invention is directed to SH3 domain derivatives having a specific binding affinity to a target molecule. In this respect, the invention provides SH3 domain derivatives of nephrocystin (NPHP1) and the Tec kinase. The invention also provides a method for the production of a library comprising recombinant derivatives of NPHP1 or the Tec kinase SH3 domains and a method for selecting from the library one or more derivatives of the SH3 domain of nephrocystin (NPHP1) or the Tec kinase having a specific binding affinity to a target molecule.
Public/Granted literature
- US20180230456A1 SH3 domain derivatives Public/Granted day:2018-08-16
Information query
IPC分类: